According to the researchers behind the study, the GLP-1 liraglutide appears to work on migraines through two possible pathways
Most patients experience rapid rebound hunger within one to four weeks after stopping semaglutide, since GLP-1 receptor sensitivity returns to baseline
This variability underscores the importance of biomarker-guided personalization
Regular check-ups, reporting new or worsening symptoms, discussing all medications, and asking questions ensure ongoing communication with healthcare providers
The medication supports the process, but it does not replace the underlying work of building healthier patterns
The procedures also carry small but real risks of serious complications including leaks, infections, and blood clots